Cargando…

Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients

The goal was to study the phenotypic manifestations of c.3844T>C (p.Trp1282Arg, W1282R) variant, a CF-causing mutation, in patients from the Russian Federation. Clinical manifestations and complications (the age at CF diagnosis, sweat test, pancreatic status, lung function, microbial infection, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrova, Nika V., Kashirskaya, Nataliya Y., Krasovskiy, Stanislav A., Amelina, Elena L., Kondratyeva, Elena I., Marakhonov, Andrey V., Vasilyeva, Tatyana A., Voronkova, Anna Y., Sherman, Victoria D., Ginter, Evgeny K., Kutsev, Sergey I., Zinchenko, Rena A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600230/
https://www.ncbi.nlm.nih.gov/pubmed/32992607
http://dx.doi.org/10.3390/genes11101137
_version_ 1783603093899837440
author Petrova, Nika V.
Kashirskaya, Nataliya Y.
Krasovskiy, Stanislav A.
Amelina, Elena L.
Kondratyeva, Elena I.
Marakhonov, Andrey V.
Vasilyeva, Tatyana A.
Voronkova, Anna Y.
Sherman, Victoria D.
Ginter, Evgeny K.
Kutsev, Sergey I.
Zinchenko, Rena A.
author_facet Petrova, Nika V.
Kashirskaya, Nataliya Y.
Krasovskiy, Stanislav A.
Amelina, Elena L.
Kondratyeva, Elena I.
Marakhonov, Andrey V.
Vasilyeva, Tatyana A.
Voronkova, Anna Y.
Sherman, Victoria D.
Ginter, Evgeny K.
Kutsev, Sergey I.
Zinchenko, Rena A.
author_sort Petrova, Nika V.
collection PubMed
description The goal was to study the phenotypic manifestations of c.3844T>C (p.Trp1282Arg, W1282R) variant, a CF-causing mutation, in patients from the Russian Federation. Clinical manifestations and complications (the age at CF diagnosis, sweat test, pancreatic status, lung function, microbial infection, body mass index (BMI), the presence of meconium ileus (MI), diabetes, and severe liver disease) were compared in four groups: group 1—patients carrying c.3844T>C and severe class I or II variant in trans; group 2—3849+10kbC>T/F508del patients; group 3—F508del/F508del patients; and group 4—patients with W1282R and “mild” variant in trans. Based on the analyses, W1282R with class I or II variant in trans appears to cause at least as severe CF symptoms as F508del homozygotes as reflected in the early age of diagnosis, high sweat chloride concentration, insufficient pancreatic function, and low lung function, in contrast to 3849+10kbC-T/F508del compound heterozygotes having milder clinical phenotypes. The W1282R pathogenic variant is seemed to lead to severe disease phenotype with pancreatic insufficiency similarly to the F508del homozygous genotype.
format Online
Article
Text
id pubmed-7600230
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76002302020-11-01 Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients Petrova, Nika V. Kashirskaya, Nataliya Y. Krasovskiy, Stanislav A. Amelina, Elena L. Kondratyeva, Elena I. Marakhonov, Andrey V. Vasilyeva, Tatyana A. Voronkova, Anna Y. Sherman, Victoria D. Ginter, Evgeny K. Kutsev, Sergey I. Zinchenko, Rena A. Genes (Basel) Article The goal was to study the phenotypic manifestations of c.3844T>C (p.Trp1282Arg, W1282R) variant, a CF-causing mutation, in patients from the Russian Federation. Clinical manifestations and complications (the age at CF diagnosis, sweat test, pancreatic status, lung function, microbial infection, body mass index (BMI), the presence of meconium ileus (MI), diabetes, and severe liver disease) were compared in four groups: group 1—patients carrying c.3844T>C and severe class I or II variant in trans; group 2—3849+10kbC>T/F508del patients; group 3—F508del/F508del patients; and group 4—patients with W1282R and “mild” variant in trans. Based on the analyses, W1282R with class I or II variant in trans appears to cause at least as severe CF symptoms as F508del homozygotes as reflected in the early age of diagnosis, high sweat chloride concentration, insufficient pancreatic function, and low lung function, in contrast to 3849+10kbC-T/F508del compound heterozygotes having milder clinical phenotypes. The W1282R pathogenic variant is seemed to lead to severe disease phenotype with pancreatic insufficiency similarly to the F508del homozygous genotype. MDPI 2020-09-27 /pmc/articles/PMC7600230/ /pubmed/32992607 http://dx.doi.org/10.3390/genes11101137 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Petrova, Nika V.
Kashirskaya, Nataliya Y.
Krasovskiy, Stanislav A.
Amelina, Elena L.
Kondratyeva, Elena I.
Marakhonov, Andrey V.
Vasilyeva, Tatyana A.
Voronkova, Anna Y.
Sherman, Victoria D.
Ginter, Evgeny K.
Kutsev, Sergey I.
Zinchenko, Rena A.
Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
title Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
title_full Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
title_fullStr Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
title_full_unstemmed Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
title_short Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients
title_sort clinical presentation of the c.3844t>c (p.trp1282arg, w1282r) variant in russian cystic fibrosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600230/
https://www.ncbi.nlm.nih.gov/pubmed/32992607
http://dx.doi.org/10.3390/genes11101137
work_keys_str_mv AT petrovanikav clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT kashirskayanataliyay clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT krasovskiystanislava clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT amelinaelenal clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT kondratyevaelenai clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT marakhonovandreyv clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT vasilyevatatyanaa clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT voronkovaannay clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT shermanvictoriad clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT ginterevgenyk clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT kutsevsergeyi clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients
AT zinchenkorenaa clinicalpresentationofthec3844tcptrp1282argw1282rvariantinrussiancysticfibrosispatients